Antimicrobial Efficacy of Riboflavin/UVA Combination (365 nm) In Vitro for Bacterial and Fungal Isolates: A Potential New Treatment for Infectious Keratitis-Reference-Cited by-同舟云学术

Antimicrobial Efficacy of Riboflavin/UVA Combination (365 nm) In Vitro for Bacterial and Fungal Isolates: A Potential New Treatment for Infectious Keratitis

Published:2008-08-01 Issue:8 Volume:49 Page:3402
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Martins Suy Anne R.¹,Combs Juan Castro¹,Noguera Guillermo¹,Camacho Walter¹,Wittmann Priscila¹,Walther Rhonda²,Cano Marisol¹,Dick James²,Behrens Ashley¹

Affiliation:

1. From The Wilmer Ophthalmological Institute and the

2. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A double-masked, sham-controlled trial of rose bengal photodynamic therapy for the treatment of fungal and acanthamoeba keratitis: Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction (REAGIR) study;Trials;2024-08-28

2. A double-masked, sham-controlled trial of rose bengal photodynamic therapy for the treatment of fungal and acanthameoba keratitis: Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction (REAGIR) Study;2024-07-02

3. Photoactivated riboflavin inhibits planktonic and biofilm growth of Candida albicans and non-albicans Candida species;Microbial Pathogenesis;2024-06

4. Evaluation of photoactivated chromophore for keratitis–corneal cross‐linking (PACK‐CXL) in feline infectious keratitis—patient demographics, treatment protocols, risk factors, and treatment outcome: a retrospective study;Veterinary Ophthalmology;2024-05-05

5. Bacterial Keratitis;Keratitis - Current Perspectives;2024-02-21